Article
Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients.
Haemophilia : the official journal of the World Federation of Hemophilia - 1 Sept 2014
Lochan A, Macaulay S, Chen W C, Mahlangu J N, Krause A
Abstract excerpt
A critical complication of factor VIII (FVIII) replacement therapy in Haemophilia A (HA) treatment is inhibitor development. Known genetic factors predisposing to inhibitor development include FVIII (F8) gene mutations, ethnicity, a family history of inhibitors and FVIII haplotype mismatch. The aim of this study was to characterize and correlate these genetic factors in a cohort of South African HA patients. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
